Baseline risk factors in patients with incident giant cell arteritis during the period 1950–2009 and association with time to first cerebrovascular or venous thromboembolism event.

<p>Baseline risk factors in patients with incident giant cell arteritis during the period 1950–2009 and association with time to first cerebrovascular or venous thromboembolism event.</p

Cumulative incidence rates of venous thromboembolism and cerebrovascular events in the 244 patients with incident GCA in the period from 1950–2009 compared to the 240 subjects without GCA.

<p>Cumulative incidence rates of venous thromboembolism and cerebrovascular events in the 244 patients with incident GCA in the period from 1950–2009 compared to the 240 subjects without GCA.</p

Criteria for event inclusion in the study for venous thromboembolism and cerebrovascular events in patients with GCA and non-GCA subjects^*.

<p>Criteria for event inclusion in the study for venous thromboembolism and cerebrovascular events in patients with GCA and non-GCA subjects^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0149579#t001fn001" target="_blank">*</a>}.</p

Cumulative incidence of venous thromboembolic events.

<p>Cumulative incidence (%) of venous thromboembolism in 244 patients with incident GCA in the period 1950–2009 (solid line) compared to 240 subjects without GCA (dashed line).</p

Cumulative incidence of cerebrovascular events.

<p>Cumulative incidence (%) of cerebrovascular events in 244 patients with incident GCA in the period 1950–2009 (solid line) compared to 240 subjects without GCA (dashed line).</p